11，Ihde DC.Chemotherapy in lung cancer.N Engl J Med,1992,327(20)∶1434-1441.
22，Meert AP,Berghmans T,Branle F,et al.Phase Ⅱ and Ⅲ studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.Anticancer Res,1999,19(5C)∶4379-4390.
33，Desmond NC.New agents in the management of advanced non-small cell lung cancer.Semin Oncol,1998,25(24,Suppl 9)∶83-88.
44，Ringel I,Horwitz SB.Studies with RP 56976(taxotere): a semi-synthetic analogue of taxol.J Natl Cancer Inst,1991,83(4)∶288-291.
55，Millward MJ,Zalcberg J,Bishop JF,et al.Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.J Clin Oncol,1997,15(2)∶750-758.
66，Chevalier T,Monnier A,Douillard JY,et al.Docetaxel(Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer.Eur J Cancer,1998,34(13)∶2032-2036.
3[1]Miller AB,HoodgStraten B,stauqet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47(1):207-214.
4[2]Meert AP,Berghmans T,Branle F,et al.PhaseⅡ and Ⅲ studies with new drugs for non-small cell lung cancer:a systematic review of the literature with a methodology quality assessment[J].Anticancer Res,1999,19(5C):4379-4390.
5[3]Millward MJ,Zalcberg J,Bishop JF,et al.Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer[J].Clin Oncol,1997,15(2):750-758.
6[4]Chevalier T,Monnier A,Douillard JY,et al.Docetaxel(Taxotere) plus cisplatin:an active and well-tolerated combination in patients with advanced non-small cell lung cancer[J].Eur J Cancer,1998,34(13):2032-2036.
7Camer AL,Goa KL.Docetaxel:a review of its use in non-small cell lung cancer[J].Drug and Aging,2000,17(1):53-80.
8Belani C,Lynch T.Docetaxel(Taxotere)in combination with platinums in patients with non-small-cell lung cancer.Trial data and implications for clinical management[J].Semin Oncol,2001,28(1 suppl 2):10-14.
9American society of Clinical Oncology.Clinical practice guidelines for the treatment of unresectable non small cell cancer:A phaseⅡstudy[J].J Cih Oncol,1997,15(8):2996-3008.
